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You’ve heard the words

“You have cancer.” So now what?

Cancer Rehabilitation, that’s what.
By Leslie J. Waltke, PT – Cancer Rehabilitation Coordinator

Congratulations on choosing Aurora Health Care for your
cancer care. You are in the right place. All of our Aurora
Hospital Cancer Programs, regardless of location, have
been awarded the highest accreditation possible by the
Commission on Cancer, which means we meet important
quality patient care standards and offer multiple integrated
services, such as Cancer Rehabilitation.
Being diagnosed and treated for cancer is difficult on so
many levels: psychologically, physically and functionally to
name just a few. But there is some very promising news.
Years ago, if you injured your back or had a heart attack,
you were told to “take it easy.” However, with time and
research we have learned that “rest” is a very poor treatment
tool. Today, those with cardiac problems or physical injuries
are sent to physical therapy and encouraged to exercise.
Research is telling us the same thing about rehabilitation
and exercise during and after cancer treatment.
Aurora Health Care boasts one of the largest and highest
quality cancer rehabilitation programs in the country. What
is cancer rehabilitation? Aurora’s Cancer Rehabilitation
Team is made up of physical, occupational and speech
therapists, as well as audiologists. Depending on the type
of cancer diagnosed and the treatment prescribed, just
like after a knee surgery or stroke, a Cancer Rehabilitation
Therapist works to restore the body to a full pain-free
recovery after surgery. Rehabilitation will continue with
therapeutic exercise and a therapy program designed to

keep you healthy and strong
during chemotherapy
and radiation and
assist in speeding
recovery after
treatment.
The most common
physical symptoms
associated with cancer
treatment are fatigue,
stiffness, weakness and
pain. All of these issues
can be lessened, resolved or
prevented with rehabilitation. The American Cancer
Society recommends 60 to 180 minutes a week of exercise
during and after cancer treatment. Patients undergoing
cancer rehabilitation have also been shown to have less
pain, improved function, better strength and require fewer
hospital stays. Rehabilitation and exercise have been shown
to improve quality of life, lengthen life and in some cases
reduce the risk of cancer recurrence.
So now what? If you are not feeling strong and well, call
your doctor and get in to a cancer rehabilitation therapist
soon and let’s get you moving!

For more information about our cancer
rehabilitation program, please call 414-219-7193
or visit Aurora.org/CancerRehab.

QOPI certification, continued from page 1

practices across the country. Based on this feedback,
doctors and practices can identify areas for improvement.
To become certified, practices must submit to an
evaluation of their entire practice and documentation
standards. The QCP staff and steering group members
then verify through on-site inspection that the evaluation
and documents are correct and that the practices met
core standards in all areas of treatment, including:
• Treatment planning
• Staff training and education
• Chemotherapy orders and drug preparation
• Patient consent and education
• Safe chemotherapy administration
• Monitoring and assessment of patient well-being
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About ASCO
The American Society of Clinical Oncology (ASCO) is the
world’s leading professional organization representing
physicians who care for people with cancer. With
more than 30,000 members, ASCO is committed to
improving cancer care through scientific meetings,
educational programs and peer-reviewed journals. ASCO
is supported by its affiliate organization, the Conquer
Cancer Foundation, which funds ground-breaking
research and programs that make a tangible difference
in the lives of people with cancer. For ASCO information
and resources, visit www.asco.org. Patient-oriented
cancer information is available at www.cancer.net.

Clinical trials, continued from page 4

How to read health news
Health care headlines often seems like a yo-yo with
substances such as coffee and chocolate going from bad
to good week by week. Often the actual research articles
are not the same as the over-hyped headlines. An article
from Dr. Alicia White from 2009 is still very valuable
today.3 Reading the full article is very useful, but bullet
points include:
• Does the article support its claims with scientific
research?
• Is the article based on a conference abstract?
• Was the research in humans?
• How many people did the research study include?
• Did the study have a control group?
• Did the study actually assess what’s in the headline?
• Who paid for and conducted the study?
• Should you shoot the messenger?
• How can I find out more?
Part of being an informed and engaged health care
participant (either as a patient or a provider) includes
being both curious and critical. Explore the news, but
realize more information is not needed. This brings us
to another commonly asked question ...

Why don’t you just give us the good drug?
Tomasz Beer, MD, FACP, notes that “Without clinical
trials, cancer treatment would always remain the same.”
The drugs we have available today to treat cancer are
only here based upon patients participating in clinical
trials. We also know that theory is not proof. That is,
good ideas need to be tested initially in petri dishes, but
eventually in human beings. We can’t use cell, animal
or computer models to completely predict what will
happen when we give drugs to human cancer patients.
The reason we test drugs is that we predict they will be
better but aren’t sure.
John Mandrola, MD, notes in the Kevin.MD blog
“The hubris of medicine has to end” and “Our
interventions should never be eminence-based, but
rather, evidenced-based.” The evidence is based on
clinical trials (http://www.kevinmd.com/blog/2013/09/
hubris-medicine.html).

Myths and truths about cancer
clinical trials
Conspiracy theories may make for good summer
blockbuster movies, but aren’t helpful for making
nuanced medical decisions. Here is a collection of
clinical trial myths:

Learn About Cancer Clinical Trials – Myths & Facts
About Cancer Clinical Trials
Coalition of Cancer Cooperative Groups
http://ow.ly/qg1hG
Myths and Truths About Cancer Clinical Trials
Tom Beer and Larry Axmaker, 2012
http://ow.ly/qg2oN
Clinical Studies –Myths vs. Facts
Seattle Cancer Care Alliance
Busting Clinical Trials Myths
American Cancer Society - Katherine Sharpe, MTS
Cancer Treatment Myths: Any Truth to These Common Beliefs?
Mayo Clinic
http://www.mayoclinic.com/health/cancer/HO00033

FDA priority/Fast track/Accelerated/
Breakthrough designations
The FDA is often criticized for not approving cancer
drugs fast enough. A recent Forbes article by Matthew
Herper noted “The FDA’s Cancer Czar Says He Can’t
Approve New Drugs Fast Enough.” In fact, in 2012 the
FDA approved 39 new drugs, the most in 16 years. The
article detailed a few FDA drug designations that are
commonly in the lay and physician press. A drug can
get one or more of the designations at once.
FDA drug designations

Priority Review – Created by Congress in 1992, cuts
the targeted review time from ten to six months
Fast Track status – Streamline the review process for
drugs that meet an unmet medical need
Accelerated Approval – Allows approvel based on
preliminary data pending the completion of larger
studies
Breakthrough – FDA Safety and Innovation Act of
2012 – catalyzes communication between companies
and the FDA
These designations are designed to improve the drug
approval process. In future issues, we will discuss
specific cancers and available clinical trials available
at Aurora Health Care.
_________________________________________________________
1. Prasad V, Vandross A, Toomey C, et al: A decade of reversal: an analysis
of 146 contradicted medical practices. Mayo Clin Proc 88:790-8, 2013
2. ASCO: ASCO Completes Prototype for CancerLinQ™, Marking First
Demonstration of a “Learning Health System” to Transform Cancer
Care, 2013
3. A . W: How to read health news, 2009
Retrieved from http://www.nlm.nih.gov/hsrinfo/cer.html
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Female-focused care
By Mira Ketzler, RN, MSN – Women’s Health Program Director

As individuals, we can all attest to the fact that who we
are and how we experience life can be influenced by
many things, such as our families, social experiences,
and cultural and spiritual beliefs. There is one more
key variable that may influence our life experience and
that is gender. When talking about our own individual
health, we know that sex does matter.
Women have unique health needs, and many diseases
affect women differently than men. There are diseases
that are unique to women, such as gynecologic
cancer; occur predominately in women, such as
breast cancer; and then there are those that are
biologically and physiologically different in women,
such as cardiac disease. There is an entire new field
of scientific inquiry called “sex-based biology,”
which is “committed to identifying the biological and
physiologic differences between men and women.
There are biological differences at every level, from a
single cell to the entire body” (Society for Women’s
Health Research, www.womenshealthresearch.org).
It is important to note that prior to 1990, women
were not included in clinical trials or adequately
represented in research studies. This recognition
sparked several actions by the National Institutes of
Health to form the Office of Research on Women’s
Health, as well as pass additional regulation requiring
the inclusion of women and minorities in clinical
research (National Institutes of Health Revitalization
Act of 1993). In addition, expert organizations such
as the Society for Women’s Health Research were also
formed. Though there are many specifics yet to be
answered, we do have sound scientific evidence to
support that there are many health conditions that are
different in women, due to either a higher incidence,
different symptomology than men, and/or different
risk factors.

The Women’s Health Program at Aurora Health Care
strives to recognize these differences and implement
best practices to support health care to all women. By
combining what our female patients have shared regarding
their desired health care experience and our clinical
expertise, we’ve created programs and services that address
the unique health care needs of women. One such program
is our Incontinence and Pelvic Reconstructive Surgery
program. We bring together a group of highly trained
experts in the field of urogynecology, pelvic floor rehab
and pelvic reconstructive surgery who work together
with our patients to develop their optimal plan of care.
Integrated with this program are experts in Behavioral
Health and Sexual Health and Medicine, to provide
additional support and treatment as needed. We
partner with our cancer colleagues in a similar fashion,
to develop a female-focused cancer program that
addresses the unique needs of women. Our programs
in gynecologic oncology and breast health combine
the expertise of women’s health care providers with
the expertise of our medical, surgical and radiation
oncologists, to provide the excellence in the entire
spectrum of care from screening and early detection
through treatment and cancer survivorship.
For more information about women’s
health at Aurora Health Care, please visit
Aurora.org/WomensHealth.

The information presented in this newsletter is intended for general information and educational purposes. It is not
intended to replace the advice of your own physician. Contact your physician if you believe you have a health problem.
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